Valuation Update With 7 Day Price Move • May 11
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to NT$53.40, the stock trades at a trailing P/E ratio of 68.8x. Average trailing P/E is 32x in the Chemicals industry in Taiwan. Total returns to shareholders of 252% over the past three years. Valuation Update With 7 Day Price Move • Apr 02
Investor sentiment deteriorates as stock falls 22% After last week's 22% share price decline to NT$55.30, the stock trades at a trailing P/E ratio of 78.6x. Average trailing P/E is 27x in the Chemicals industry in Taiwan. Total returns to shareholders of 295% over the past three years. Annuncio • Mar 19
Luminescence Technology Corp., Annual General Meeting, Jun 23, 2026 Luminescence Technology Corp., Annual General Meeting, Jun 23, 2026. Location: 17- floor no,93, sec.1 hsin t`ai 5th rd., sijhih district, new taipei city Taiwan Valuation Update With 7 Day Price Move • Mar 09
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to NT$54.30, the stock trades at a trailing P/E ratio of 77.2x. Average trailing P/E is 22x in the Chemicals industry in Taiwan. Total returns to shareholders of 273% over the past three years. New Risk • Mar 02
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (16% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Profit margins are more than 30% lower than last year (13% net profit margin). Revenue is less than US$5m (NT$137m revenue, or US$4.4m). Market cap is less than US$100m (NT$1.42b market cap, or US$45.3m). New Risk • Feb 02
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Dividend is not well covered by earnings and cash flows. Payout ratio: 135% Cash payout ratio: 135% Minor Risks Profit margins are more than 30% lower than last year (13% net profit margin). Revenue is less than US$5m (NT$137m revenue, or US$4.3m). Market cap is less than US$100m (NT$1.27b market cap, or US$40.2m). Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment improves as stock rises 32% After last week's 32% share price gain to NT$48.70, the stock trades at a trailing P/E ratio of 69.2x. Average trailing P/E is 22x in the Chemicals industry in Taiwan. Total returns to shareholders of 250% over the past three years. New Risk • Sep 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 135% Cash payout ratio: 135% Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Profit margins are more than 30% lower than last year (13% net profit margin). Revenue is less than US$5m (NT$137m revenue, or US$4.5m). Market cap is less than US$100m (NT$792.6m market cap, or US$25.8m). Valuation Update With 7 Day Price Move • Sep 02
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to NT$34.40, the stock trades at a trailing P/E ratio of 48.9x. Average trailing P/E is 26x in the Chemicals industry in Taiwan. Total returns to shareholders of 139% over the past three years. Reported Earnings • Aug 19
First half 2025 earnings released: EPS: NT$0.30 (vs NT$0.29 in 1H 2024) First half 2025 results: EPS: NT$0.30 (up from NT$0.29 in 1H 2024). Revenue: NT$75.3m (up 47% from 1H 2024). Net income: NT$7.55m (up 4.2% from 1H 2024). Profit margin: 10.0% (down from 14% in 1H 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 17% per year, which means it is well ahead of earnings. Upcoming Dividend • Jul 17
Upcoming dividend of NT$0.95 per share Eligible shareholders must have bought the stock before 24 July 2025. Payment date: 16 September 2025. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 3.7%. Lower than top quartile of Taiwanese dividend payers (5.3%). Higher than average of industry peers (3.1%). Reported Earnings • Jun 04
Full year 2024 earnings released: EPS: NT$0.69 (vs NT$1.17 in FY 2023) Full year 2024 results: EPS: NT$0.69 (down from NT$1.17 in FY 2023). Revenue: NT$112.9m (up 13% from FY 2023). Net income: NT$17.4m (down 41% from FY 2023). Profit margin: 15% (down from 29% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • May 07
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to NT$25.40, the stock trades at a trailing P/E ratio of 23.2x. Average trailing P/E is 19x in the Chemicals industry in Taiwan. Total returns to shareholders of 57% over the past three years. Valuation Update With 7 Day Price Move • Apr 14
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to NT$20.45, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 18x in the Chemicals industry in Taiwan. Total returns to shareholders of 17% over the past three years. Annuncio • Mar 21
Luminescence Technology Corp., Annual General Meeting, Jun 26, 2025 Luminescence Technology Corp., Annual General Meeting, Jun 26, 2025. Location: 17- floor no,93, sec.1 hsin t`ai 5th rd., sijhih district, new taipei city Taiwan New Risk • Mar 03
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 92% Paying a dividend despite having no free cash flows. High level of non-cash earnings (43% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (6.2% average weekly change). Revenue is less than US$5m (NT$104m revenue, or US$3.2m). Market cap is less than US$100m (NT$525.9m market cap, or US$16.0m). New Risk • Jan 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 92% Paying a dividend despite having no free cash flows. High level of non-cash earnings (43% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (6.1% average weekly change). Revenue is less than US$5m (NT$104m revenue, or US$3.2m). Market cap is less than US$100m (NT$592.5m market cap, or US$18.0m). Valuation Update With 7 Day Price Move • Jan 08
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to NT$23.40, the stock trades at a trailing P/E ratio of 21.4x. Average trailing P/E is 21x in the Chemicals industry in Taiwan. Total returns to shareholders of 49% over the past three years. Upcoming Dividend • Aug 15
Upcoming dividend of NT$1.00 per share Eligible shareholders must have bought the stock before 22 August 2024. Payment date: 16 September 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 4.3%. Lower than top quartile of Taiwanese dividend payers (4.4%). Higher than average of industry peers (2.4%). Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment deteriorates as stock falls 24% After last week's 24% share price decline to NT$20.30, the stock trades at a trailing P/E ratio of 17.4x. Average trailing P/E is 24x in the Chemicals industry in Taiwan. Total returns to shareholders of 43% over the past three years. Buy Or Sell Opportunity • Jul 08
Now 25% overvalued after recent price rise Over the last 90 days, the stock has risen 51% to NT$27.45. The fair value is estimated to be NT$21.89, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.7% over the last 3 years. Earnings per share has grown by 25%. Valuation Update With 7 Day Price Move • Jul 02
Investor sentiment improves as stock rises 30% After last week's 30% share price gain to NT$24.20, the stock trades at a trailing P/E ratio of 20.8x. Average trailing P/E is 24x in the Chemicals industry in Taiwan. Total returns to shareholders of 71% over the past three years. Reported Earnings • Apr 28
Full year 2023 earnings released: EPS: NT$1.16 (vs NT$1.00 in FY 2022) Full year 2023 results: EPS: NT$1.16 (up from NT$1.00 in FY 2022). Revenue: NT$100.3m (down 7.1% from FY 2022). Net income: NT$29.3m (up 16% from FY 2022). Profit margin: 29% (up from 23% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Annuncio • Mar 23
Luminescence Technology Corp., Annual General Meeting, Jun 27, 2024 Luminescence Technology Corp., Annual General Meeting, Jun 27, 2024. Valuation Update With 7 Day Price Move • Mar 21
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to NT$19.35, the stock trades at a trailing P/E ratio of 24.6x. Average trailing P/E is 23x in the Chemicals industry in Taiwan. Total returns to shareholders of 34% over the past three years. New Risk • Mar 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 190% Cash payout ratio: 169% Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Revenue is less than US$5m (NT$99m revenue, or US$3.1m). Market cap is less than US$100m (NT$412.6m market cap, or US$13.0m). Buy Or Sell Opportunity • Feb 29
Now 22% overvalued Over the last 90 days, the stock has fallen 3.8% to NT$16.40. The fair value is estimated to be NT$13.43, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Meanwhile, the company has become profitable. Valuation Update With 7 Day Price Move • Aug 24
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to NT$15.10, the stock trades at a trailing P/E ratio of 19.2x. Average trailing P/E is 24x in the Chemicals industry in Taiwan. Total returns to shareholders of 23% over the past three years. Upcoming Dividend • Aug 15
Upcoming dividend of NT$1.50 per share at 8.5% yield Eligible shareholders must have bought the stock before 22 August 2023. Payment date: 15 September 2023. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 8.5%. Within top quartile of Taiwanese dividend payers (5.7%). Higher than average of industry peers (3.8%). Buying Opportunity • Jul 04
Now 24% undervalued The stock has been flat over the last 90 days. The fair value is estimated to be NT$21.77, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Meanwhile, the company has become profitable. Buying Opportunity • Jun 02
Now 22% undervalued The stock has been flat over the last 90 days. The fair value is estimated to be NT$22.06, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Meanwhile, the company has become profitable. Buying Opportunity • May 11
Now 21% undervalued Over the last 90 days, the stock is up 5.8%. The fair value is estimated to be NT$21.99, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Meanwhile, the company has become profitable. Reported Earnings • Apr 30
Full year 2022 earnings released: EPS: NT$1.00 (vs NT$0.86 in FY 2021) Full year 2022 results: EPS: NT$1.00 (up from NT$0.86 in FY 2021). Revenue: NT$107.9m (up 3.8% from FY 2021). Net income: NT$25.3m (up 16% from FY 2021). Profit margin: 23% (up from 21% in FY 2021). Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Aug 11
Upcoming dividend of NT$0.78 per share Eligible shareholders must have bought the stock before 18 August 2022. Payment date: 08 September 2022. Payout ratio is on the higher end at 90%, however this is supported by cash flows. Trailing yield: 4.5%. Lower than top quartile of Taiwanese dividend payers (6.6%). Lower than average of industry peers (7.9%). Reported Earnings • May 02
Full year 2021 earnings released: EPS: NT$0.86 (vs NT$0.23 in FY 2020) Full year 2021 results: EPS: NT$0.86 (up from NT$0.23 in FY 2020). Revenue: NT$104.0m (up 24% from FY 2020). Net income: NT$21.8m (up 268% from FY 2020). Profit margin: 21% (up from 7.0% in FY 2020). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Mar 17
Investor sentiment improved over the past week After last week's 16% share price gain to NT$23.70, the stock trades at a trailing P/E ratio of 36.3x. Average trailing P/E is 17x in the Chemicals industry in Taiwan. Total returns to shareholders of 39% over the past year. Valuation Update With 7 Day Price Move • Feb 26
Investor sentiment improved over the past week After last week's 26% share price gain to NT$23.95, the stock trades at a trailing P/E ratio of 36.7x. Average trailing P/E is 18x in the Chemicals industry in Taiwan. Total returns to shareholders of 91% over the past year. Valuation Update With 7 Day Price Move • Dec 06
Investor sentiment improved over the past week After last week's 15% share price gain to NT$20.90, the stock trades at a trailing P/E ratio of 32x. Average trailing P/E is 17x in the Chemicals industry in Taiwan. Total returns to shareholders of 57% over the past year. Reported Earnings • May 02
Full year 2020 earnings released: EPS NT$0.24 (vs NT$0.39 loss in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: NT$84.2m (down 2.9% from FY 2019). Net income: NT$5.92m (up NT$15.7m from FY 2019). Profit margin: 7.0% (up from net loss in FY 2019). The move to profitability was driven by lower expenses. Annuncio • Mar 20
Luminescence Technology Corp., Annual General Meeting, Jun 29, 2021 Luminescence Technology Corp., Annual General Meeting, Jun 29, 2021. Is New 90 Day High Low • Feb 18
New 90-day low: NT$13.15 The company is down 7.0% from its price of NT$14.10 on 18 November 2020. The Taiwanese market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period. Is New 90 Day High Low • Feb 02
New 90-day low: NT$13.90 The company is down 3.0% from its price of NT$14.30 on 05 November 2020. The Taiwanese market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. Is New 90 Day High Low • Oct 21
New 90-day high: NT$16.60 The company is up 11% from its price of NT$15.00 on 23 July 2020. The Taiwanese market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 1.0% over the same period. Is New 90 Day High Low • Sep 24
New 90-day low: NT$14.30 The company is down 5.0% from its price of NT$15.10 on 24 June 2020. The Taiwanese market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 3.0% over the same period.